Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors [NA]
A Barbara Ann Karmanos Cancer Institute study aims to address social determinants of health among cancer survivors in Metro Detroit and is c…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Ivonescimab in the Treatment of Multiple Advanced Tumors [Phase 2]
An update indicating Ivonescimab is being studied in a Phase 2 trial for multiple advanced tumors and is currently recruiting. The trial cov…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours [Phase 2]
Phase 2 clinical study evaluating cessation of somatostatin analogue therapy after PRRT in midgut, hindgut, and pancreatic neuroendocrine tu…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours [Phase 2]
Phase 2 clinical trial evaluating Lutetium-177 Octreotate Therapy for neuroendocrine tumors is currently recruiting. The study is sponsored …
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: 68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs) [NA]
A completed clinical trial evaluating Gallium-68 DOTATATE PET-CT for diagnosing neuroendocrine tumors (NETs).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Open-Label Surufatinib in European Patients With NET [Phase 2]
An open-label Phase 2 trial of surufatinib in European patients with neuroendocrine tumors was terminated, with results posted in 2025.
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 study evaluating lenvatinib for metastatic neuroendocrine tumors has completed. Results were posted on July 24, 2025.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases [Phase 2]
Phase 2 trial evaluating intra-arterial hepatic infusion of radiolabeled somatostatin analogs in patients with gastroenteropancreatic neuroe…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: 177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry [Phase 2]
This clinical trial update describes a Phase 2 study of individualized dosimetry-based delivery of Lutathera (177Lu-DOTATATE) for neuroendoc…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent [EARLY_Phase 1]
This Clinical Trial Update reports a first-in-human Phase 1 trial of an alpha-radiation imaging agent for neuroendocrine tumors (Grade 1 and…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating a dual-targeting tracer TATE-RGD for imaging SSTR- and RGD-positive tumors. The study targets iod…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: 68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours [Phase 2]
Phase 2 clinical trial evaluating 68Ga-labeled octreotide analogue PET imaging in duodenal and pancreatic neuroendocrine tumors. The study s…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study [Phase 2]
Phase 2 CABATEN trial evaluated cabozantinib in combination with atezolizumab for advanced neuroendocrine neoplasms of the endocrine system.…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: DOTATOC PET/CT for Imaging NET Patients
ClinicalTrials.gov entry describes a DOTATOC PET/CT imaging study for neuroendocrine tumors, sponsored by the British Columbia Cancer Agency…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region.
The clinical trial is currently recruiting to evaluate quality of life and tolerance of vectorized internal radiotherapy (RIV) in patients w…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET [Phase 1]
A Phase 1 study of AlphaMedix™ in adults with SSTR-positive neuroendocrine tumors was terminated.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies [NA]
Clinical trial update for 177Lu-CTR-FAPI in advanced metastatic digestive cancers; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors [Phase 1]
Phase 1 clinical trial update exploring the combination of PARP inhibitors with peptide receptor radionuclide therapy for neuroendocrine tum…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: 61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET) [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating the PET imaging agent 61Cu-NODAGA-LM3 for detecting neuroendocrine tumors; recruitment is currently…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Life Following Excision of Neuroendocrine Tumors
An update on a clinical trial studying outcomes after surgical excision of neuroendocrine tumors; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors [Phase 3]
Phase 3 trial evaluating SUV on 68Ga-DOTATATE PET/CT and Ki-67 index in neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor [Phase 3]
Phase 3 trial evaluating sequential therapy with Everolimus followed by STZ-5FU in advanced pancreatic neuroendocrine tumors has completed a…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: 68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors [Phase 2]
A Phase 2 clinical trial is evaluating 68Ga-HA-DOTATATE PET imaging for suspected somatostatin receptor–positive neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver [EARLY_Phase 1]
This clinical trial update describes an early-phase study of Lutathera in people with gastroenteropancreatic, bronchial, or unknown primary …
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Evaluation of [18F]Fluoroethyl Triazole Labelled [Tyr3]-Octreotate Analogues for the Imaging of Neuroendocrine Tumours. [Phase 1, Phase 2]
Phase 1/2 study evaluating a radiolabeled [Tyr3]-octreotate analogue for PET imaging of neuroendocrine tumors; the trial has completed and r…